Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Ga-PentixaFor PET/CT

Phase 2Small molecule

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Clinical

Trials by Indication[1]

Inflammation1 trial

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

Recruiting·JJohn O. Prior·Phase 2·NCT05499637·69 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Ga-PentixaFor PET/CT. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ga-PentixaFor PET/CT compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ga-PentixaFor PET/CT. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — John O. Prior company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: JJohn O. Prior

Related News